DCTPP1 exhibits a strong preference for dCTP and its analogs, including 5-iodo-dCTP and 5-methyl-dCTP . The enzyme also displays weak activity against deoxythymidine triphosphate (dTTP) and deoxyadenosine triphosphate (dATP), but it does not act on deoxyguanosine triphosphate (dGTP) . This specificity is essential for maintaining the balance of nucleotide pools within the cell and preventing the incorporation of potentially harmful nucleotide analogs into DNA or RNA .
The activity of DCTPP1 is vital for several cellular processes:
Research on DCTPP1 has implications for understanding various genetic disorders and diseases related to nucleotide metabolism. The enzyme’s role in eliminating excess dCTP and preventing overmethylation of CpG islands makes it a potential target for therapeutic interventions in conditions where these processes are disrupted .